ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Alzheimer's drug combo faces safety test
Disease control Not yet recruitingThis study aims to check if a new drug combination called X/T+X-EC is safe and tolerable for people with Alzheimer's disease who are already being treated with the medication lecanemab. It will involve 60 participants aged 60-85 over 32 weeks. Participants will be randomly assign…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Brain drain surgery: a bold new attack on Alzheimer's
Disease control Not yet recruitingThis study is testing whether a surgical procedure on the neck's drainage system, combined with standard care, can slow the progression of moderate-to-severe Alzheimer's disease. It will compare this surgery to standard care alone in about 376 patients across China. The main goal…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New drug trial aims to stop Alzheimer's before it starts in High-Risk group
Prevention Not yet recruitingThis study is testing an investigational drug called HT-4253 to see if it can prevent Alzheimer's disease in people who carry the APOE4 gene and have early biological signs of the disease but no memory symptoms. It will enroll 112 healthy adults aged 50-75. Participants will rece…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Apr 04, 2026 05:22 UTC